药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Benzonatate
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypoglycemic activities of Sunitinib.
Benzonatate
Caroxazone
Caroxazone may increase the hypoglycemic activities of Sunitinib.
Benzonatate
Safrazine
Safrazine may increase the hypoglycemic activities of Sunitinib.
Benzonatate
Pivhydrazine
Pivhydrazine may increase the hypoglycemic activities of Sunitinib.
Benzonatate
Phenoxypropazine
Phenoxypropazine may increase the hypoglycemic activities of Sunitinib.
Benzonatate
Pheniprazine
Pheniprazine may increase the hypoglycemic activities of Sunitinib.
Benzonatate
Octamoxin
Octamoxin may increase the hypoglycemic activities of Sunitinib.
Benzonatate
Mebanazine
Mebanazine may increase the hypoglycemic activities of Sunitinib.
Benzonatate
Benmoxin
Benmoxin may increase the hypoglycemic activities of Sunitinib.
Benzonatate
Hydracarbazine
Hydracarbazine may increase the hypoglycemic activities of Sunitinib.
Benzonatate
Toloxatone
Toloxatone may increase the hypoglycemic activities of Sunitinib.
Benzonatate
Pirlindole
Pirlindole may increase the hypoglycemic activities of Sunitinib.
Benzonatate
Nialamide
Nialamide may increase the hypoglycemic activities of Sunitinib.
Benzonatate
Iproniazid
Iproniazid may increase the hypoglycemic activities of Sunitinib.
Benzonatate
Pargyline
Pargyline may increase the hypoglycemic activities of Sunitinib.
Benzonatate
Rasagiline
Rasagiline may increase the hypoglycemic activities of Sunitinib.
Benzonatate
Isocarboxazid
Isocarboxazid may increase the hypoglycemic activities of Sunitinib.
Benzonatate
Moclobemide
Moclobemide may increase the hypoglycemic activities of Sunitinib.
Benzonatate
Encorafenib
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Encorafenib.
Benzonatate
Emedastine
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Emedastine.